The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects.

Simple Summary: The purpose of this study is to emphasize the importance of genetic testing for healthy individuals with a strong family history of hereditary malignancies. A total of 103 healthy subjects with at least two relatives with cancer were enrolled. By NGS analysis of 27 genes, 5% were fou...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 16; no. 13; pp. 2327 - 2337
Autores principales: Pilenzi, Lucrezia, Anaclerio, Federico, Dell'Elice, Anastasia, Minelli, Maria, Giansante, Roberta, Cicirelli, Michela, Tinari, Nicola, Grassadonia, Antonino, Pantalone, Andrea, Grossi, Simona, Canale, Nicole, Bruno, Annalisa, Calabrese, Giuseppe, Ballerini, Patrizia, Stuppia, Liborio, Antonucci, Ivana
Formato: research tables/charts Journal Article
Publicado: MDPI Jul2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=178695908&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 178695908
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Jul2024
      vid: 16
      iid: 13
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        178695908
        178695908
        178695908
        10.3390/cancers16132327
        178695908
      ppf: 2327
      ppct: 10
      formats:
      tig:
        atl: The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects.
      aug:
        au:
          Pilenzi, Lucrezia
          Anaclerio, Federico
          Dell'Elice, Anastasia
          Minelli, Maria
          Giansante, Roberta
          Cicirelli, Michela
          Tinari, Nicola
          Grassadonia, Antonino
          Pantalone, Andrea
          Grossi, Simona
          Canale, Nicole
          Bruno, Annalisa
          Calabrese, Giuseppe
          Ballerini, Patrizia
          Stuppia, Liborio
          Antonucci, Ivana
        affil: Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy
      sug:
        subj:
          Neoplasms Familial and Genetic
          Family
          Neoplasms Risk Factors
          Risk Assessment
          Genetic Screening
          Human
          Retrospective Design
          Record Review
          Oncogenes
          Mutation
          Individualized Medicine
          Genomics
          Sequence Analysis
      ab: Simple Summary: The purpose of this study is to emphasize the importance of genetic testing for healthy individuals with a strong family history of hereditary malignancies. A total of 103 healthy subjects with at least two relatives with cancer were enrolled. By NGS analysis of 27 genes, 5% were found to carry a pathogenic variant in a hereditary cancer susceptibility gene. In the era of personalized medicine, genetic testing of healthy subjects in the absence of a living affected collateral is crucially important for early diagnosis, clinical surveillance and surgical choice. Hereditary cancer syndromes caused by germline mutations account for 5–10% of all cancers. The finding of a genetic mutation could have far-reaching consequences for pharmaceutical therapy, personalized prevention strategies, and cascade testing. According to the National Comprehensive Cancer Network's (NCCN) and the Italian Association of Medical Oncology (AIOM) guidelines, unaffected family members should be tested only if the affected one is unavailable. This article explores whether germline genetic testing may be offered to high-risk families for hereditary cancer even if a living affected relative is missing. A retrospective study was carried out on 103 healthy subjects tested from 2017 to 2023. We enrolled all subjects with at least two first- or second-degree relatives affected by breast, ovarian, pancreatic, gastric, prostate, or colorectal cancer. All subjects were tested by Next Generation Sequencing (NGS) multi-gene panel of 27 cancer-associated genes. In the study population, 5 (about 5%) pathogenic/likely pathogenic variants (PVs/LPVs) were found, while 40 (42%) had a Variant of Uncertain Significance (VUS). This study highlights the importance of genetic testing for individuals with a strong family history of hereditary malignancies. This approach would allow women who tested positive to receive tailored treatment and prevention strategies based on their personal mutation status.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N